Objectives: Our study aimed at estimating the prevalence of neuropsychiatric symptoms and investigating associated factors among older adults living in two countries in Central Africa (Central African Republic [CAR] and Republic of Congo
| INTRODUCTION
Neuropsychiatric symptoms, also called behavioural and psychological symptoms of dementia (BPSD), are often associated with neurocognitive disorders. Prevalence of BPSD between 50.0% and 100.0% were reported worldwide among people with dementia, with the most common symptoms being apathy, agitation, and depression. [1] [2] [3] Only a few studies focusing on BSPD were conducted in low-and middle-income countries (LMIC). In a multicentre study performed across 17 LMIC, at least one BPSD was reported in 70.9% of the 555 participants with dementia. 4 In sub-Saharan Africa (SSA), neuropsychiatric symptoms were investigated in community-based studies. These symptoms were present in 61.9% of older participants with normal cognition, 90.6% of Mild Cognitive Impairment (MCI) participants, and 79.4% of participants with dementia in Nigeria. 5 In
Tanzania, the prevalence of neuropsychiatric symptoms was estimated at 64.0% in controls and 88.4% in people with dementia. 6 According to the World Health Organization, neuropsychiatric disorders are responsible for 6.6% of Disability-Adjusted Life Years (DALYs) among people aged 60 and over. 7 BPSD increase the burden in people with dementia and their caregivers. 8 They are leading to poorer quality of life, mood disorders, and psychological distress among caregivers. 9 In SSA, people with dementia are mainly cared for by family members and live in the community, 10 while health care systems are not yet equipped to cope with increasing health issues of ageing populations, 11 adding to the burden experienced.
To date, there are no studies on neuropsychiatric symptoms among older adults in Central Africa. The present study aimed at estimating the prevalence of neuropsychiatric symptoms and investigating associated factors in older people living in two Central Africa countries, the Central African Republic (CAR) and the Republic of Congo (ROC). This study is part of the Epidemiology of Dementia in Central Africa (EPIDEMCA) programme, which main objectives were to estimate the prevalence of dementia and cognitive disorders and to evaluate associated factors among older people from rural and urban areas of Central Africa.
| MATERIALS AND METHODS

| Design and participants
The EPIDEMCA multicentre population-based survey included 2002 adults aged 65 years and over, living in the capitals of CAR (Bangui) and ROC (Brazzaville) and rural areas (Nola in CAR and Gamboma in ROC) between November 2011 and December 2012. The detailed methodology has been described elsewhere. 12 Sample size was estimated at 500 in each study site, based on an expected dementia prevalence of 5% with a precision of 2% (EpiInfo 6.04, Epiconcept). A random sampling proportional to the size of each main subdivision of the city and a door-to-door approach were used, respectively, in urban sites and rural areas to select participants.
A two-phase design was performed. In the first phase, all subjects had a physical examination while socio-demographic and vascular risk factors were assessed with a structured questionnaire. Cognitive screening was based on the Community Screening Interview for Dementia (CSI-D), 13 and mental state was evaluated through the Geriatric Mental State (GMS).
14 Assessments were performed in local languages (Sango in CAR, Lari, Kituba, and Lingala in ROC) after a translation and back translation process, followed by a consensus with clinicians and study investigators to ensure conceptual equivalence.
Participants with a low cognitive performance at the CSI-D (≤24.5) were suspected of cognitive impairment/dementia. In the sec- 
| Assessment of neuropsychiatric symptoms
The Neuropsychiatric Inventory (NPI) is one of the most commonly used instruments to assess BPSD 20 and has previously been used and validated in African populations, 6, 10 underlining its transcultural value. The NPI-Q (validated French version translated into local languages) was performed by trained clinicians with experience of neurological and psychiatric assessments, ensuring an accurate description of the symptoms.
Based on interviews with the informant, the NPI-Q measures the frequency, severity, and stress of neuropsychiatric symptoms over the last 30 days. It was originally developed for the assessment of 10
Key points
• Prevalence of neuropsychiatric symptoms among older people with neurocognitive disorders is high in CAR and ROC.
• Both presence of neuropsychiatric symptoms and their number increased with the severity of the cognitive impairment.
• The most frequent symptoms reported were depression, anxiety, irritability, sleep and night-time behaviour disorders, delusions, and apathy.
• Difficulties in eating, physical disability, female sex, and dementia were significantly associated with neuropsychiatric symptoms.
neuropsychiatric symptoms in community-dwelling dementia patients. 21 Two other neuropsychiatric symptoms have subsequently been added and a distress score was developed to assess the emotional or psychological impact of individual symptoms. 
| Other assessments
All covariates were collected during the first phase. Sociodemographic data included age, sex, marital status, education, site (Nola, Bangui, Gamboma, Brazzaville), and self-reported friendships in the community.
Age was ascertained either from official documents, an informant report or estimated using the historical events. 28 In this study, marital status was dichotomized into "married/living as a couple" and "not married"
(including single, widowed, and divorced participants), as were education ("no formal education" and "some formal education" [i.e. attended (yes/no) were also collected. Indication on happiness was collected using the Center for Epidemiologic Studies Depression Scale. 30 Stressful life events according to Persson and Skoog questionnaire 31 and psychoactive drug abuse (opioids, hallucinogens, barbiturates, hypnotics and tranquilizers as explored in the GMS) were also investigated.
| Statistical analysis
All data were computerized directly on the field using an interface To investigate independent factors associated with neuropsychiatric symptoms, a univariate analysis using logistic regression models was performed with neuropsychiatric symptoms (at least one/none)
as the dependent variable. Variables that had a P value lower than 0.2 in the univariate analysis were included in a multivariate logistic regression model. Backward stepwise elimination procedure was realized, and confounders and interactions were examined, leading to a final model with a level of statistical significance of 0.05.
| RESULTS
| Characteristics of the study sample
Among the 2002 participants, 775 had a low CSI-D cognitive score (≤24.5) and were invited to the clinical interview of the second phase.
Of them, 556 were assessed, due to 111 lost to follow-up, 14 deaths, 35 recurrent absences, 10 moving, and 50 refusals. Of the 556 participants assessed, 532 participants with complete NPI-Q data were included in the current study ( Figure 1 ). Characteristics, including age, sex, marital status, and education, were similar for participants included in the study (n = 532) and the ones excluded from the study (n = 243) (Supporting Information Table S1 ). Regarding countries, the proportion of female participants seemed greater, although not significantly, in CAR than ROC (P = 0.4). More participants were cognitively impaired in CAR than in ROC (P = 0.001).
Similarly, the proportion of participants with physical disability was significantly lower in ROC than CAR (P < 0.0001). Participants were more hypertensive (P < 0.0001) and had more history of stroke in both urban than rural areas (P = 0.03). Demographic and clinical characteristics of participants by site are shown in Table 1 .
Participants with dementia had significantly more physical disability (54.6%) than participants with MCI (45.1%) and participants with no MCI nor dementia (32.0%) (P = 0.001). Participants with dementia were also less likely to have friends in the community (P = 0.0001) and normal hearing (P = 0.003). They were older (P < 0.0001) and had less formal education (P = 0.3) than participants with no MCI nor dementia. Characteristics of participants according their cognitive status are summarized in Supporting Information Table S2 .
| Neuropsychiatric symptoms
Overall, at least one neuropsychiatric symptom was reported by 63.7% (95% CI, 59.5-67. reported three or more. The most frequent symptoms were depression, anxiety, and irritability ( Table 2 ).
The prevalence of neuropsychiatric symptoms was greater in urban than rural areas (P < 0.0001), and in CAR than ROC (P < 0. In CAR, the most frequent symptoms were depression and anxiety. In ROC, it was irritability and depression (Supporting Information Table S3 ).
| Influence of cognitive status
The prevalence of neuropsychiatric symptoms increased with cognitive impairment. In participants with no MCI nor dementia, 48.7% (95% CI, among participants with no MCI nor dementia (P < 0.0001). Table 2 shows the prevalence of each symptom according to cognitive status. Regardless of sites, the most common symptoms were depression, anxiety, and irritability. Apart from sleep, night-time behaviour, appetite and eating disorders, the prevalence of all symptoms was significantly higher in people with dementia than those with MCI and those with no MCI nor dementia ( reported three or more, 20.0% of VaD participants had one or two symptoms, and 53.3% had three symptoms or more.
There were no significant differences in symptom patterns between dementia subtypes compared with the rest of the participants. The most frequent symptoms remained depression, anxiety, and irritability (Supporting Information Table S4 ).
| Associated factors
After adjustment on age and education, participants living in Gamboma (OR = 0.12; 95% CI, 0.05-0.24), with normal hearing (Table 3) .
| DISCUSSION
Our study shows that neuropsychiatric symptoms are common in CAR and ROC among older people with neurocognitive disorders. The prevalence of symptoms was significantly higher in participants with dementia than in those with MCI or those with no MCI nor dementia;
the number of symptoms also increased with cognitive impairment.
Our results are similar to those reported in community-based studies from other SSA countries. Indeed, in both Nigeria 5 and Tanzania, 6 the prevalence of neuropsychiatric symptoms was significantly higher in the MCI group than in the normal group, 90.6% vs 61.9% and 88.4% vs 64.0%, respectively. Likewise, in Tanzania, the number of symptoms reported was higher in dementia than in MCI and control participants. Overall, the high prevalence of symptoms in dementia estimated in our study (89.9%) is in the same range as those reported in Nigeria and Tanzania (79.4% in Nigeria and 88.4% in Tanzania).
The most frequent symptoms were depression, anxiety, and irritability. The pattern of neuropsychiatric symptoms observed was relatively similar to those reported in other SSA countries. 5, 6 In these community-based studies, depression was also the most frequent symptom in MCI and dementia; however, its prevalence was lower than what we observed. Indeed, in Nigeria, depression was reported by Abbreviations: C2, chi square; MCI, mild cognitive impairment.
Symptoms in bold are the three most frequently reported. 45.3% of participants with MCI and 44.1% of participants with dementia, 5 and in Tanzania, depression was present in 32.6% of MCI and 33.3% of dementia participants. 6 Alongside depression, apathy and aberrant motor behaviour were also reported in MCI and dementia, and night-time behaviour among people was cognitively normal in Nigeria. 5 Anxiety and irritability were the next commonest symptoms after depression in Tanzania. 6 In our study, no difference in symptoms pattern was found between AD and VaD. This result may be explained by the small number of VaD included, thus limiting statistical power.
Differences in symptom patterns between the two subtypes of dementia were found in Tanzania, where anxiety, depression, and irritability were common among participants with AD while agitation, anxiety, and sleep and night-time behaviour disorders were the most reported in people with VaD. Despite being smaller, a more balanced distribution between AD and VaD (38 AD and 32 VaD) was observed in that study. 6 Prevalence of neuropsychiatric symptoms was significantly higher in urban than in rural area and also in CAR than in ROC. These findings might reflect cultural differences in understanding and reporting of neuropsychiatric symptoms between CAR and ROC and/or between the rural and urban areas. There might also be differences between sociodemographic and clinical characteristics of the countries contributing to those results. Indeed, difficulties in eating and physical disability were more frequent in CAR than in ROC as was dementia. These factors, identified as associated with the presence of neuropsychiatric symptoms here, may partly explain the higher prevalence of symptoms in CAR. A higher prevalence of symptoms observed in urban areas could have several potential origins. People living in urban areas could be more exposed to some risk factors such as stress. Neuropsychiatric symptoms could also be less reported in rural areas because older people were better integrated in the community, as social network (participating in religious activities, having friends in the community, and playing board games) was greater in these areas. Having friends is a socializing factor that may be protective of dementia 32 and thus neuropsychiatric symptoms. However, it is also possible that the absence of neuropsychiatric symptoms allow individuals to have friends and a better social network as neuropsychiatric symptoms can be stigmatizing. 33 Unfortunately, the design of our study and the data available do not allow us to draw any definitive conclusion.
Normal hearing was another factor identified as potentially protective against neuropsychiatric symptoms. Although we cannot totally rule out the potential impact of hearing difficulties on the measurement of cognitive impairment and neuropsychiatric symptoms, recent evidence supports the association between sensory loss and neuropsychiatric symptoms among people with neurocognitive disorders. Vision and hearing loss are two conditions that may participate to the expression of neuropsychiatric symptoms. 34 Sensory loss leads to communication issues and reduced social engagement as well as social isolation. [35] [36] [37] While hearing loss has been linked to single neuropsychiatric symptoms (psychosis) 38 and agitation, 39 poor vision and self-reported hearing difficulties were associated with a greater number of neuropsychiatric symptoms in a community-based study in Australia. Physical disability was associated with a 2-fold increase in the likelihood of neuropsychiatric symptoms in our sample. 41 Neuropsychiatric symptoms may influence everyday function and lead to increased disability, but some symptoms, such as depression and anxiety, may also be the result of physical impairment. The crosssectional design of our study limits our interpretation.
34
Female participants showed a significantly higher risk of having neuropsychiatric symptoms in our study. The association between sex and neuropsychiatric symptoms was not explored in the study from Tanzania while it was not significant in both Nigeria and the 10/66 Dementia Research Group study in LMICs. 4 Education was not associated with the presence of neuropsychiatric symptoms in our sample. However, considering the high proportion of females in our sample and their low education levels, we cannot rule out that we lacked statistical power to detect a significant effect in our study or a possible cultural factor, with women reporting more symptoms than men. As this association remained significant even after adjustment in this study, it deserves to be further investigated in future studies to understand its mechanisms.
As could be expected, the strongest association identified was the one between dementia and neuropsychiatric symptoms, with a 7-fold increase in risk. There is strong evidence worldwide supporting the link between dementia and neurocognitive disorders in the occurrence of neuropsychiatric symptoms among older people. 42 Unfortunately, differences in study designs prevent us to do direct comparisons of its effect size with studies carried out in SSA or other LMIC.
A major strength of our study lies in the fact that it is one of the very few studies on neuropsychiatric symptoms among older people carried out in SSA and the first in Central Africa. Apart from being population based, another asset of the present study is the high quality of the cognitive diagnosis relying on a comprehensive assessment including psychometric testing and informant interview, conducted by trained neurologists, ruling out any alternative psychiatric diagnosis, and validated by a consensus of experts. Neuropsychiatric symptoms were also assessed using the NPI-Q, which is to date one of the most commonly used instruments 20 to assess behavioural and psychological symptoms of dementia. Although not specifically validated in this context, it has previously been used and validated in other African settings. 6, 10 However, we acknowledge some limitations. The sample of participants assessed by the NPI-Q, derived from participants with suspected cognitive impairment (second stage of EPIDEMCA), may have led to an overestimation of the prevalence of neuropsychiatric symptoms in our study. We also acknowledge that the use of translation versions of NPI-Q in local languages, although unavoidable, could be a limitation in our study due to the lack of formal validation. However, questionnaires used in the EPIDEMCA study were translated from French to local languages, then from local languages to French in order to observe translation consistency following the WHO guidelines. These translations were performed by a group of independent linguistic professionals, which then received the input of bilingual clinicians and study investigators in order to reach a consensus on the translations aiming at conceptual equivalence rather than literal translations. Moreover, the NPI-Q was filled by the interviewers (all fluent in the relevant languages) during the examination. We therefore believe we were able to limit the possible issues related to the meaning of the symptoms.
Over 200 participants selected for the second stage were not assessed because of loss of follow-up, death, or refusals. However, the absence of significant difference between their characteristics (sex, age, education, and marital status) and the ones of the participants included, rules out the possibility of a major selection bias at that stage.
We therefore believe that only the generalizability of those results to all older people living in settings of CAR and ROC is limited as those results cannot be generalized to elderly with normal cognition.
In conclusion, the prevalence and number of neuropsychiatric symptoms increased with cognitive impairment in our study 
